Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1391, 2003-01, pp. : 17-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ancrod may not provide clinical benefit to patients with acute ischaemic stroke
Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. :
The use of a sirolimus-eluting stent leads to long-term reductions in clinical restenosis
Inpharma, Vol. 1, Iss. 1536, 2006-01 ,pp. :
Benefit-Risk Assessment of Sirolimus in Renal Transplantation
Drug Safety, Vol. 28, Iss. 2, 2005-01 ,pp. :
Reirradiation of recurrent medulloblastoma: Does clinical benefit outweigh risk for toxicity?
Cancer, Vol. 120, Iss. 23, 2014-12 ,pp. :